Skip to main content
. Author manuscript; available in PMC: 2012 Aug 15.
Published in final edited form as: Biochem Pharmacol. 2011 May 18;82(4):411–417. doi: 10.1016/j.bcp.2011.05.009

Table 3.

Profile of deoxyribonucleotide pool normalized with ATP.

Compound Retention
time(min)
ionization
mode
linear
range(pmol)
PANC1 1975 HepG2 H23

pmol/106cell
dATP 39.5 negative 0.25 - 60 28.50±1.56 16.57 ± 0.89 4.24 ± 0.34 12.75 ± 0.84
dADP 23.1 negative 0.072 - 5.6 0.65±0.07 0.28 ± 0.04 0.00 ± 0.00 0.00 ± 0.00
dAMP 16.6 negative 0.0086 - 1.36 0.08±0.01 0.03 ± 0.00 0.08 ± 0.02 0.00 ± 0.00
dGTP 41.0 positive 0.25 - 60 15.77±0.72 7.60 ± 0.40 7.40 ± 0.72 7.07 ± 0.56
dGDP 23.6 positive 0.082-10.4 2.69±0.19 1.06 ± 0.07 1.37 ± 0.20 0.96 ± 0.25
dGMP 15.3 positive 0.1 - 12.8 UDL* UDL* UDL* UDL*
dCTP 30.8 negative 0.25 - 60 18.54±1.00 7.96 ± 0.67 4.20 ± 0.40 9.12 ± 0.66
dCDP 20.2 negative 0.076-6.166 UDL* UDL* UDL* UDL*
dCMP 10.6 negative 0.1 - 8 1.40±0.20 0.29 ± 0.04 1.45 ± 0.18 0.82 ± 0.05
dUTP 42.4 negative 0.95 - 38 UDL* UDL* UDL* UDL*
dUDP 21.7 negative 0.1-16 UDL* UDL* UDL* UDL*
dUMP 13.5 negative 0.1 - 8 6.36±1.12 8.15 ± 1.52 23.77 ± 4.79 3.55 ± 0.95
TTP 41.2 negative 0.25 - 60 91.64±4.26 62.12 ± 2.54 18.35 ± 1.63 68.32 ± 7.33
TDP 22.8 negative 0.42 - 9 20.23±2.28 13.74 ± 1.52 13.80 ± 1.80 11.72 ± 1.31
TMP 14.8 negative 0.0172 - 1.36 0.42±0.07 0.14±0.02 0.95 ± 0.18 0.17 ± 0.03

Note: Each data point is an average of two independent experiments (done in triplicate) and is reported as mean ± standard deviation.

*

UDL, under detected limit of assay.